RAPT Therapeutics, Inc. (RAPT)
USD 0.82
(-2.75%)
USD 0.82
(-2.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.52 Million | 3.81 Million | 5.04 Million | - | - |
| Cost of Revenue | 3.55 Million | 2.8 Million | 996 Thousand | - | 1.33 Million | 1.23 Million |
| Gross Profit | -3.55 Million | -1.28 Million | 2.81 Million | 5.04 Million | -1.33 Million | -1.23 Million |
| Operating Expenses | 127.06 Million | 87.32 Million | 73.02 Million | 58.25 Million | 43.62 Million | 36.94 Million |
| Selling, General and Administrative Expenses | 26.06 Million | 20.24 Million | 16.03 Million | 12.77 Million | 8.71 Million | 5.18 Million |
| Research and Development Expenses | 101 Million | 67.08 Million | 56.98 Million | 45.48 Million | 34.91 Million | 31.76 Million |
| Other Expenses | - | 1.95 Million | 5000.00 | 1.31 Million | 1.29 Million | 800 Thousand |
| Cost and Expenses | 127.06 Million | 87.32 Million | 73.02 Million | 58.25 Million | 43.62 Million | 36.94 Million |
| Operating Income | -127.06 Million | -85.79 Million | -69.2 Million | -53.21 Million | -43.62 Million | -36.94 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -1.95 Million | -996 Thousand | 990 Thousand | 660 Thousand | 800 Thousand |
| Earnings before Tax | -116.79 Million | -83.83 Million | -69.2 Million | -51.9 Million | -42.33 Million | -36.14 Million |
| Net Income | -116.79 Million | -81.88 Million | -68.2 Million | -52.89 Million | -42.99 Million | -36.14 Million |
| Earnings Per Share Basic | -3.05 | -2.52 | -2.49 | -2.19 | -1.97 | -2.09 |
| Earnings Per Share Diluted | -3.05 | -2.52 | -2.49 | -2.19 | -1.97 | -2.09 |
| Weighted Average Shares Outstanding | 38.33 Million | 32.54 Million | 27.39 Million | 24.13 Million | 21.83 Million | 17.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.33 Million | 32.54 Million | 27.39 Million | 24.13 Million | 21.83 Million | 17.32 Million |
| Gross Margin | - | -0.84 | 0.74 | 1.00 | - | - |
| EBIT Margin | - | -56.19 | -18.15 | -10.55 | - | - |
| Profit Margin | - | -53.62 | -17.89 | -10.49 | - | - |
| EBITDA | -125.84 Million | -84.74 Million | -68.21 Million | -52.09 Million | -42.29 Million | -35.71 Million |
| Earnings Before Tax Margin | - | -56.19 | -18.15 | -10.55 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 5.28 Million | - | - |
| Cost of Revenue | 305 Thousand | 314 Thousand | 3.55 Million | 323 Thousand | 908 Thousand | 853 Thousand |
| Gross Profit | -305 Thousand | -314 Thousand | -3.55 Million | 4.96 Million | -908 Thousand | -853 Thousand |
| Operating Expenses | 29.02 Million | 32.2 Million | 123.51 Million | 32.89 Million | 33.91 Million | 28.36 Million |
| Selling, General and Administrative Expenses | 6.38 Million | 7.42 Million | - | 6.13 Million | 6.89 Million | 6.72 Million |
| Research and Development Expenses | 22.64 Million | 24.78 Million | - | 26.76 Million | 27.02 Million | 21.64 Million |
| Other Expenses | 1.66 Million | 1.99 Million | - | 2.34 Million | 2.54 Million | 3.08 Million |
| Cost and Expenses | 29.33 Million | 32.51 Million | 127.06 Million | 33.21 Million | 33.91 Million | 28.36 Million |
| Operating Income | -29.33 Million | -32.51 Million | -127.06 Million | -33.21 Million | -33.91 Million | -28.36 Million |
| Interest Expense | - | - | - | 2.29 Million | - | - |
| Income Tax Expense | - | 270.72 Thousand | - | 2.88 Million | -325 Thousand | -269 Thousand |
| Earnings before Tax | -27.66 Million | -30.52 Million | -116.79 Million | -30.87 Million | -31.37 Million | -25.28 Million |
| Net Income | -27.66 Million | -30.52 Million | -116.79 Million | -30.87 Million | -31.37 Million | -25.28 Million |
| Earnings Per Share Basic | -0.71 | -0.79 | - | -0.80 | -0.82 | -0.66 |
| Earnings Per Share Diluted | -0.71 | -0.79 | - | -0.80 | -0.82 | -0.66 |
| Weighted Average Shares Outstanding | 38.86 Million | 38.62 Million | 38.33 Million | 38.38 Million | 38.35 Million | 38.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.86 Million | 38.62 Million | 38.33 Million | 38.38 Million | 38.35 Million | 38.32 Million |
| Gross Margin | - | - | - | 0.94 | - | - |
| EBIT Margin | - | - | - | -6.22 | - | - |
| Profit Margin | - | - | - | -5.84 | - | - |
| EBITDA | -29.02 Million | -32.2 Million | - | -32.89 Million | -33.91 Million | -28.36 Million |
| Earnings Before Tax Margin | - | - | - | -6.28 | - | - |
SBYSF
PIFYF
GTII
NBG6
2440
300634